Company Badge
USPTO Data Jan 1 1976 - Oct 27 2026
5 Patents
#87 in Alpharetta, GA
#994 in Georgia
#51,669 in US
Aviragen Therapeutics, Inc.
Forward Citations = 1
17 inventors:
Alpharetta, GA, United States of America
Aviragen Therapeutics, Inc.
Calculating rank
% Expired Patents = 20.0
Forward Citations = 1
Loading Chart...
Loading Chart...
17 inventors (with patents filed for the assignee):
Delphine Compere (3 out of 8 patents)
Marta Blumenfeld (3 out of 38 patents)
Marco A Ciufolini (1 out of 19 patents)
4. Jean-Michel Gauthier (1 out of 4 patents)
5. Edward Lee (1 out of 2 patents)
6. David McAllister (1 out of 1 patent)
7. Andrew Trigwell (1 out of 1 patent)
8. Peter Snyder, Jr (1 out of 1 patent)
9. Christa Leisa Frassetto (1 out of 1 patent)
10. Patricia Francon (1 out of 1 patent)
11. Michel Hutin (1 out of 1 patent)
12. Tyrone Pieter Jeynes (1 out of 5 patents)
13. Alistair George Draffan (1 out of 15 patents)
14. Michael Harding (1 out of 7 patents)
15. Rosliana Halim (1 out of 5 patents)
5 patents:
Company Overview
Aviragen Therapeutics, Inc. is a biotechnology company focused on the discovery and development of antiviral therapeutics. The company's pipeline includes treatments for respiratory syncytial virus (RSV) and influenza, with a mission to address unmet medical needs in infectious diseases. Aviragen is dedicated to advancing innovative therapies that have the potential to improve patient outcomes and reduce the burden of viral infections.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aviragen Therapeutics, Inc.. Retrieved from https://idiyas.com/company/aviragen-therapeutics
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]